In collaboration with University of California Berkeley and Microvi, Nexilico will develop this comprehensive in silico solution, supported by rigorous experimental validation, to reliably identify and characterize microbial metabolism of drugs. The proposed methods will increase the reliability of predictions for clinical and commercial use.
Read More